-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NxV7qhMC4VTI+0Q5Mvts0KCFI5HgoXlkVnpLRL0zqiSrphJER8DmjRtCkbAgyDzW 8jFgErSECB6DHGg5I3R9qA== 0001140361-10-011208.txt : 20100310 0001140361-10-011208.hdr.sgml : 20100310 20100310180218 ACCESSION NUMBER: 0001140361-10-011208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100303 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCINERNEY TIMOTHY CENTRAL INDEX KEY: 0001226020 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 10671737 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 doc1.xml FORM 4 X0303 4 2010-03-03 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHAN 0001226020 MCINERNEY TIMOTHY C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET, SUITE 1110 NEW YORK NY 10005 1 0 0 0 Common Stock 2010-03-08 4 J 0 6347 A 674007 D Warrant 1.44 2010-08-30 Common Stock 29721 29721 D Warrant 1.49 2010-08-30 Common Stock 27500 27500 D Stock Options 0.97 2014-09-27 Common Stock 100000 100000 D Stock Options 1.00 2015-01-11 Common Stock 25000 25000 D Stock Options 0.71 2017-01-30 Common Stock 50000 50000 D Stock Options 0.17 2018-03-25 Common Stock 75000 75000 D Warrant 0.20 2013-09-10 Common Stock 24000 24000 D Stock Options 0.07 2010-03-03 4 A 0 300000 0 A 2020-03-02 Common Stock 300000 300000 D Received in exchange for 16,668 shares of common stock of Ariston Pharmaceuticals, Inc. ("Ariston") in connection with the merger (the "Ariston Merger") of Ariston with a wholly-owned subsidiary of Manhattan Pharmaceuticals, Inc. (the "Company"). On the effective date of the Ariston Merger, the closing price of the Company's common stock ("Common Stock") was $0.065 per share, and there was no market price for Ariston's common stock because Ariston was a private company. The warrants are exercisable immediately. The option vested as to 33,334 shares on September 27, 2004, and as to an additional 33,333 shares on each of September 27, 2005 and September 27, 2006. The option vested as to 8,334 shares on January 11, 2005, and as to an additional 8,333 shares on each of January 11, 2006 and January 11, 2007. The option vested as to 16,667 shares on each of January 30, 2007 and January 30, 2008, and as to the remaining 16,666 shares on January 30, 2009. The option vested as to 41,667 shares on March 25, 2008 and as to an additional 16,667 shares on March 25, 2009. The remaining 16,666 shares are scheduled to vest on March 25, 2010. On March 3, 2010, the reporting person was granted an option to purchase 300,000 shares of Common Stock under the 2003 Stock Option Plan. The vesting schedule of the option is as follows: (i) 250,000 shares vested on the date of grant, (ii) 16,667 shares are scheduled to vest on each of March 3, 2011 and March 3, 2012, and (iii) 16,666 shares are scheduled to vest on March 3, 2013. /s/ Timothy McInerney 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----